APA

Gattaz W. F., Campos J. A. d. O., Lacerda A. L. T., Henna E., Ruschel S. I., Bressan R. A., de Oliveira I. R., Rocha F. L., Grabowski H. M., Sacomani E., Louzã M. R., Quevedo J., Elkis H., Zorzetto Filho D., Périco C. d. A., Lawson F. L. & Appolinário J. C. (20141217). Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study. : Current medical research and opinion.

Chicago

Gattaz Wagner F, Campos João Alberto de Oliveira, Lacerda Acioly L T, Henna Elaine, Ruschel Sandra Inês, Bressan Rodrigo A, de Oliveira Irismar Reis, Rocha Fábio Lopes, Grabowski Hamilton M, Sacomani Ernindo, Louzã Mario R, Quevedo João, Elkis Hélio, Zorzetto Filho Dirceu, Périco Cintia de Azevedo-Marques, Lawson Fábio Lorea and Appolinário José Carlos. 20141217. Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study. : Current medical research and opinion.

Harvard

Gattaz W. F., Campos J. A. d. O., Lacerda A. L. T., Henna E., Ruschel S. I., Bressan R. A., de Oliveira I. R., Rocha F. L., Grabowski H. M., Sacomani E., Louzã M. R., Quevedo J., Elkis H., Zorzetto Filho D., Périco C. d. A., Lawson F. L. and Appolinário J. C. (20141217). Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study. : Current medical research and opinion.

MLA

Gattaz Wagner F, Campos João Alberto de Oliveira, Lacerda Acioly L T, Henna Elaine, Ruschel Sandra Inês, Bressan Rodrigo A, de Oliveira Irismar Reis, Rocha Fábio Lopes, Grabowski Hamilton M, Sacomani Ernindo, Louzã Mario R, Quevedo João, Elkis Hélio, Zorzetto Filho Dirceu, Périco Cintia de Azevedo-Marques, Lawson Fábio Lorea and Appolinário José Carlos. Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study. : Current medical research and opinion. 20141217.